Biotest AG is a DE-based company operating in Biotechnology industry. The company is headquartered in Dreieich, Hessen and currently employs 2,495 full-time employees. Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology, and intensive care medicine. The company develops, manufactures, and markets immunoglobulin, coagulation factors, and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.
Milyon USD cinsinden finanslar. Mali yıl Şubat - Ocak'tır.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Hasılat
635
726
684
516
515
484
Hasılat Artışı (YoY)
-16%
6%
33%
0%
6%
16%
Satınalma Maliyeti
487
502
404
391
434
354
Brüt Kâr
147
223
280
124
80
130
Satış, Genel ve İdari
85
79
73
72
72
69
Araştırma ve Geliştirme
56
56
66
49
51
55
İşletme Giderleri
135
137
160
141
130
132
Diğer Finansman Gelirleri (Giderleri)
--
-2
-2
-5
-3
-3
Kâr Öncesi Gelir
-25
46
106
-30
-62
-30
Kira Vergisi Gideri
-1
20
-20
0
0
1
Net Kâr
-24
26
127
-32
-64
-32
Net Income Growth
Kâr Artışı
-115.99%
-80%
-497%
-50%
100%
700%
Dolaşım Daki Hisse Senetleri (Dilüte Edilmiş)
38.9
39.57
39.57
39.57
39.57
39.57
Hisse Değişimi (Yıllık Üst Üste)
-2%
0%
0%
0%
0%
0%
EPS (Diluted)
-0.62
0.67
3.21
-0.82
-1.64
-0.81
EPS Artışı
-115.99%
-79%
-491%
-50%
102%
575%
Öz sermaye akışı
14
32
-36
-69
15
-43
Hisse Başı Öz Kaynak Akışı
--
--
--
--
--
--
Brüt Karşılık
23.14%
30.71%
40.93%
24.03%
15.53%
26.85%
Faaliyet Kâr Marjı
1.73%
11.84%
17.54%
-3.1%
-9.7%
-0.41%
Kâr Marjı
-3.77%
3.58%
18.56%
-6.2%
-12.42%
-6.61%
Özsermaye Karlılık Oranı
2.2%
4.4%
-5.26%
-13.37%
2.91%
-8.88%
EBITDA
--
126
155
19
-19
27
EBITDA Marjinali
--
17.35%
22.66%
3.68%
-3.68%
5.57%
D&A EBITDA için
--
40
35
35
31
29
Faaliyet Kârı
11
86
120
-16
-50
-2
Faaliyet Kâr Marjı
1.73%
11.84%
17.54%
-3.1%
-9.7%
-0.41%
Verilen Vergi Oranı
4%
43.47%
-18.86%
0%
0%
-3.33%
Follow-Up Questions
¿Cuáles son los estados financieros clave de Biotest Aktiengesellschaft?
Según el último estado financiero (Form-10K), Biotest Aktiengesellschaft tiene un total de activos de $1,434, una ganancia neta kâr de $26
¿Cuáles son los ratios financieros clave para BTTAY?
El ratio corriente de Biotest Aktiengesellschaft es 1.58, el margen neto es 3.58, las ventas por acción son $18.34.
¿Cómo se desglosan los ingresos de Biotest Aktiengesellschaft por segmento o geografía?
Biotest Aktiengesellschaft en büyük gelir kaynağı European Union olup, en son kar bildiriminde geliri 260,399,999 dir. Coğrafi olarak, Rest of the World , Biotest Aktiengesellschaft için ana pazar olup, geliri 234,100,000 dir.
¿Es rentable Biotest Aktiengesellschaft?
evet, según los últimos estados financieros, Biotest Aktiengesellschaft tiene una ganancia neta kâr de $26
¿Tiene Biotest Aktiengesellschaft alguna deuda?
evet, Biotest Aktiengesellschaft tiene una deuda de 903
¿Cuántas acciones en circulación tiene Biotest Aktiengesellschaft?
Biotest Aktiengesellschaft tiene un total de acciones en circulación de 39.57